Lonza wins $7m US NIH stem cell contract

Related tags Stem cell

Lonza wins $7m US NIH stem cell contract
Lonza wins $7m US NIH stem cell contract
Lonza has won a second US NIH contract to manufacture stem cells for medical research.

The three-year contract – which is worth around $7m (€5.3m) – will see the Swiss life sciences supply the National Institutes of Health Centre for Regenerative Medicine with clinical grade induced pluripotent stem cells (iPCSs) made at its facility in Walkersville, Maryland in the US.

Lonza won its first stem cell production contract with the NIH in 2012 a few years after founding its Pluripotent Stem Cell Innovation Center which – according to Stephan Kutzer, COO Lonza Pharma-Biotech - has develop the processes needed to manufacture stem cells on a commercial scale.

"First, the group was tasked with developing technologies to help the field move pluripotent stem cell derived therapies to the clinic.  Second, it was tasked with providing a comprehensive service offering to support both basic and clinical PSC research.  This latest NIH contract validates Lonza's investments in this key strategic area."​   

Related topics Bio Developments Cell lines

Related news

Show more

Related products

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

Follow us

Products

View more

Webinars